You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 1
  • Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

Citation Tools

Article menu
Download PDFPDF
ORIGINAL ARTICLE
Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fuso L, Amant F, Neven P, et al
Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients
International Journal of Gynecologic Cancer 2006;16:60-67.